Roy Walford and the immunologic theory of aging

Roy Walford died on April 27, 2004, at the age of 79. His contributions to gerontological research in such diverse areas as caloric restriction, genetics of lifespan, immunosenescence, DNA repair and replicative senescence were truly remarkable in their depth and innovation. Significantly, most of t...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Immunity & ageing Ročník 2; číslo 1; s. 7
Hlavný autor: Effros, Rita B
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England BioMed Central 25.04.2005
BMC
Predmet:
ISSN:1742-4933, 1742-4933
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Roy Walford died on April 27, 2004, at the age of 79. His contributions to gerontological research in such diverse areas as caloric restriction, genetics of lifespan, immunosenescence, DNA repair and replicative senescence were truly remarkable in their depth and innovation. Significantly, most of the areas that he pioneered during his illustrious research career remain the "hot" areas of current gerontological research. In this sense, he has achieved the most important type of immortality. His death was a major personal and professional loss to numerous scientists within the gerontological community. In launching this new journal on Immunity and Ageing, it is highly fitting, therefore, to remember him on the anniversary of his death by briefly reviewing the contributions of Roy Walford to this important facet of gerontology. Indeed, it was Roy who actually first coined the commonly used term "immunosenescence".
AbstractList Roy Walford died on April 27, 2004, at the age of 79. His contributions to gerontological research in such diverse areas as caloric restriction, genetics of lifespan, immunosenescence, DNA repair and replicative senescence were truly remarkable in their depth and innovation. Significantly, most of the areas that he pioneered during his illustrious research career remain the "hot" areas of current gerontological research. In this sense, he has achieved the most important type of immortality. His death was a major personal and professional loss to numerous scientists within the gerontological community. In launching this new journal on Immunity and Ageing, it is highly fitting, therefore, to remember him on the anniversary of his death by briefly reviewing the contributions of Roy Walford to this important facet of gerontology. Indeed, it was Roy who actually first coined the commonly used term "immunosenescence".
Abstract Roy Walford died on April 27, 2004, at the age of 79. His contributions to gerontological research in such diverse areas as caloric restriction, genetics of lifespan, immunosenescence, DNA repair and replicative senescence were truly remarkable in their depth and innovation. Significantly, most of the areas that he pioneered during his illustrious research career remain the "hot" areas of current gerontological research. In this sense, he has achieved the most important type of immortality. His death was a major personal and professional loss to numerous scientists within the gerontological community. In launching this new journal on Immunity and Ageing, it is highly fitting, therefore, to remember him on the anniversary of his death by briefly reviewing the contributions of Roy Walford to this important facet of gerontology. Indeed, it was Roy who actually first coined the commonly used term "immunosenescence".
Roy Walford died on April 27, 2004, at the age of 79. His contributions to gerontological research in such diverse areas as caloric restriction, genetics of lifespan, immunosenescence, DNA repair and replicative senescence were truly remarkable in their depth and innovation. Significantly, most of the areas that he pioneered during his illustrious research career remain the "hot" areas of current gerontological research. In this sense, he has achieved the most important type of immortality. His death was a major personal and professional loss to numerous scientists within the gerontological community. In launching this new journal on Immunity and Ageing, it is highly fitting, therefore, to remember him on the anniversary of his death by briefly reviewing the contributions of Roy Walford to this important facet of gerontology. Indeed, it was Roy who actually first coined the commonly used term "immunosenescence".Roy Walford died on April 27, 2004, at the age of 79. His contributions to gerontological research in such diverse areas as caloric restriction, genetics of lifespan, immunosenescence, DNA repair and replicative senescence were truly remarkable in their depth and innovation. Significantly, most of the areas that he pioneered during his illustrious research career remain the "hot" areas of current gerontological research. In this sense, he has achieved the most important type of immortality. His death was a major personal and professional loss to numerous scientists within the gerontological community. In launching this new journal on Immunity and Ageing, it is highly fitting, therefore, to remember him on the anniversary of his death by briefly reviewing the contributions of Roy Walford to this important facet of gerontology. Indeed, it was Roy who actually first coined the commonly used term "immunosenescence".
ArticleNumber 7
Author Effros, Rita B
AuthorAffiliation 1 Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA Los Angeles, CA 90024, USA
AuthorAffiliation_xml – name: 1 Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA Los Angeles, CA 90024, USA
Author_xml – sequence: 1
  givenname: Rita B
  surname: Effros
  fullname: Effros, Rita B
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15850487$$D View this record in MEDLINE/PubMed
BookMark eNp9kktr3TAQRkVJaB7tstviVcnGid6PTaGE5gGBQGjpUozlsaNgW6nsG7j_vnZueklCyEoa6czRB6MDsjOkAQn5wugxY1afMCN5KZ0QJS_NB7K_rXee7ffIwTjeUSqk0_Ij2WPKKiqt2ScnN2ld_IGuSbkuYKiL6RaL2PerIXWpjWGpU14XqSmgjUP7iew20I34-Wk9JL_Pfv46vSivrs8vT39clUE4Z0qjXFUBUEfRUK4CmGA514KDRS10QIq64aziwiqwmjZMVg4r0BiqWs3IIbnceOsEd_4-xx7y2ieI_vEg5dZDnmLo0CukvKHGQkOtlFRVQTHJKDJrg5mfn13fN677VdVjHXCYMnQvpC9vhnjr2_TgGRPMsSXMtydBTn9XOE6-j2PAroMB02r0nFphjWUzePQuyKxyUhtqFvTr81DbNP9HMwNiA4ScxjFj40OcYIppyRg7z6hfPoBfhuyXIXvul67yVddW_Cb_D0_Wrv4
CitedBy_id crossref_primary_10_3390_ijms232113059
crossref_primary_10_1016_j_trac_2015_09_011
crossref_primary_10_3390_ijerph192013220
crossref_primary_10_1186_s12979_021_00232_1
crossref_primary_10_1007_s40520_013_0190_y
crossref_primary_10_1089_rej_2008_0662
crossref_primary_10_1186_s12979_022_00313_9
crossref_primary_10_1016_j_jep_2023_116286
crossref_primary_10_1016_j_arr_2016_06_005
crossref_primary_10_1586_erv_10_27
crossref_primary_10_2174_1381612825666191111155800
crossref_primary_10_1007_s11154_022_09726_9
crossref_primary_10_1016_j_nutres_2014_09_006
crossref_primary_10_1038_s41569_024_01108_9
crossref_primary_10_3389_fpubh_2023_1330106
crossref_primary_10_1007_s11357_014_9686_4
crossref_primary_10_1007_s11553_010_0228_3
crossref_primary_10_1016_j_exger_2007_05_006
crossref_primary_10_1016_j_semcancer_2025_02_012
crossref_primary_10_3389_fmed_2021_661203
crossref_primary_10_1016_j_arr_2024_102272
crossref_primary_10_1007_s00508_013_0419_y
crossref_primary_10_1186_s12979_024_00418_3
crossref_primary_10_1038_s41556_025_01698_7
crossref_primary_10_1016_j_rx_2024_12_001
crossref_primary_10_1007_s10522_025_10286_z
crossref_primary_10_3390_jpm12111817
crossref_primary_10_1080_87559129_2012_751547
crossref_primary_10_3390_antiox10121930
crossref_primary_10_1007_s11357_011_9353_y
crossref_primary_10_1016_j_idc_2022_11_001
crossref_primary_10_1080_14737140_2022_2139242
crossref_primary_10_1016_j_arr_2022_101833
crossref_primary_10_1186_s12979_022_00309_5
crossref_primary_10_3390_biology9090282
crossref_primary_10_3390_ijms22137016
crossref_primary_10_1152_ajpcell_00153_2025
crossref_primary_10_1007_s10522_017_9696_6
crossref_primary_10_3389_fimmu_2024_1375730
crossref_primary_10_1007_s10522_024_10101_1
crossref_primary_10_1016_j_semcancer_2025_01_002
crossref_primary_10_1186_s12951_024_02501_9
crossref_primary_10_3390_vaccines9080911
crossref_primary_10_1186_s12979_024_00473_w
crossref_primary_10_25040_ntsh2025_01_15
crossref_primary_10_59368_agingbio_20250041
crossref_primary_10_1007_s00281_020_00810_3
crossref_primary_10_1007_s11357_024_01147_7
Cites_doi 10.1126/science.1080147
10.1016/S1471-4906(02)02255-X
10.1016/j.it.2004.05.006
10.1016/j.exger.2004.03.002
10.1016/0198-8859(84)90006-5
10.1016/0014-4827(61)90192-6
10.1093/geronj/49.2.B65
10.1146/annurev.immunol.22.012703.104644
10.1016/S0167-5699(97)01079-7
10.1016/S0197-4580(02)00043-X
10.1016/j.exger.2004.03.029
10.1016/j.exger.2003.09.004
10.1006/excr.1996.0299
10.1016/0014-4827(65)90211-9
10.1016/0047-6374(93)90121-7
10.2741/A831
10.1016/j.exger.2004.03.011
10.1126/science.181845
10.1016/j.exger.2004.03.005
10.1038/268154a0
10.1126/science.307.5707.208
10.1016/0531-5565(89)90009-0
ContentType Journal Article
Copyright Copyright © 2005 Effros; licensee BioMed Central Ltd. 2005 Effros; licensee BioMed Central Ltd.
Copyright_xml – notice: Copyright © 2005 Effros; licensee BioMed Central Ltd. 2005 Effros; licensee BioMed Central Ltd.
DBID AAYXX
CITATION
NPM
7X8
7T5
H94
5PM
DOA
DOI 10.1186/1742-4933-2-7
DatabaseName CrossRef
PubMed
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals (WRLC)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList
AIDS and Cancer Research Abstracts

PubMed
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Social Welfare & Social Work
Biology
EISSN 1742-4933
EndPage 7
ExternalDocumentID oai_doaj_org_article_5e02f078af084405bc51410e188c7e70
PMC1131916
15850487
10_1186_1742_4933_2_7
Genre Journal Article
GroupedDBID ---
0R~
29I
2VQ
2WC
4.4
53G
5GY
5VS
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BFQNJ
BMC
C1A
C6C
CITATION
CS3
DIK
E3Z
EBD
EBLON
EBS
EJD
ESX
F5P
GROUPED_DOAJ
GX1
H13
HYE
IAO
IHR
IPNFZ
KQ8
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
RBZ
RIG
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
WOQ
WOW
XSB
~8M
-56
-5G
-A0
-BR
ACRMQ
ADINQ
ALIPV
C24
NPM
7X8
7T5
H94
5PM
ID FETCH-LOGICAL-c3997-759bbaa090e7025ca7c822632a8e636ce0e6f21b2385a860f14b9eba6ecbd5e63
IEDL.DBID DOA
ISSN 1742-4933
IngestDate Fri Oct 03 12:33:53 EDT 2025
Thu Aug 21 18:24:47 EDT 2025
Fri Sep 05 06:37:11 EDT 2025
Sun Aug 24 03:59:33 EDT 2025
Thu Jan 02 22:03:48 EST 2025
Sat Nov 29 03:39:03 EST 2025
Tue Nov 18 21:42:14 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3997-759bbaa090e7025ca7c822632a8e636ce0e6f21b2385a860f14b9eba6ecbd5e63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/5e02f078af084405bc51410e188c7e70
PMID 15850487
PQID 1859467071
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_5e02f078af084405bc51410e188c7e70
pubmedcentral_primary_oai_pubmedcentral_nih_gov_1131916
proquest_miscellaneous_20838781
proquest_miscellaneous_1859467071
pubmed_primary_15850487
crossref_citationtrail_10_1186_1742_4933_2_7
crossref_primary_10_1186_1742_4933_2_7
PublicationCentury 2000
PublicationDate 2005-04-25
PublicationDateYYYYMMDD 2005-04-25
PublicationDate_xml – month: 04
  year: 2005
  text: 2005-04-25
  day: 25
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Immunity & ageing
PublicationTitleAlternate Immun Ageing
PublicationYear 2005
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References L Hayflick (13_CR11) 1961; 25
DA Morgan (13_CR13) 1976; 193
LA Panossian (13_CR24) 2003; 24
G Wick (13_CR25) 2004; 22
S Gillis (13_CR12) 1977; 268
J Dausset (13_CR1) 2004; 39
RB Effros (13_CR19) 1997; 18
RA Miller (13_CR4) 2004; 39
DA Garsin (13_CR8) 2003; 300
RB Effros (13_CR20) 2003; 38
C Caruso (13_CR23) 2005; 307
EL Cooper (13_CR2) 2004; 39
NL Perillo (13_CR14) 1989; 24
13_CR17
AG Bodnar (13_CR22) 1996; 228
RB Effros (13_CR9) 1984; 9
G Pawelec (13_CR16) 2002; 7
G Pawelec (13_CR7) 2004; 25
G Pawelec (13_CR6) 2002; 23
JP Johnson (13_CR18) 1983
L Hayflick (13_CR10) 1965; 37
RL Walford (13_CR5) 1969
GB Ferrara (13_CR3) 2004; 39
RB Effros (13_CR21) 1994; 49
NL Perillo (13_CR15) 1993; 67
12493553 - Neurobiol Aging. 2003 Jan-Feb;24(1):77-84
13905658 - Exp Cell Res. 1961 Dec;25:585-621
14698803 - Exp Gerontol. 2003 Nov-Dec;38(11-12):1243-9
15275638 - Trends Immunol. 2004 Aug;25(8):406-10
7128889 - Dev Comp Immunol. 1982 Summer;6(3):391-3
12817143 - Science. 2003 Jun 20;300(5627):1921
181845 - Science. 1976 Sep 10;193(4257):1007-8
12103341 - Trends Immunol. 2002 Jul;23(7):330-2
8892971 - Exp Cell Res. 1996 Oct 10;228(1):58-64
2786475 - Exp Gerontol. 1989;24(3):177-87
6607244 - Hum Immunol. 1984 Jan;9(1):49-65
145543 - Nature. 1977 Jul 14;268(5616):154-6
15655081 - Science. 2005 Jan 14;307(5707):208-9; author reply 208-9
15032582 - Annu Rev Immunol. 2004;22:361-403
14315085 - Exp Cell Res. 1965 Mar;37:614-36
8469029 - Mech Ageing Dev. 1993 Feb;67(1-2):173-85
8126348 - J Gerontol. 1994 Mar;49(2):B65-70
9293162 - Immunol Today. 1997 Sep;18(9):450-4
11991846 - Front Biosci. 2002 May 01;7:d1056-183
References_xml – volume: 300
  start-page: 1921
  year: 2003
  ident: 13_CR8
  publication-title: Science
  doi: 10.1126/science.1080147
– volume: 23
  start-page: 330
  year: 2002
  ident: 13_CR6
  publication-title: Trends Immunol
  doi: 10.1016/S1471-4906(02)02255-X
– volume: 25
  start-page: 406
  year: 2004
  ident: 13_CR7
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2004.05.006
– ident: 13_CR17
– volume: 39
  start-page: 879
  year: 2004
  ident: 13_CR1
  publication-title: Exp Gerontol
  doi: 10.1016/j.exger.2004.03.002
– volume: 9
  start-page: 49
  year: 1984
  ident: 13_CR9
  publication-title: Hum Immunol
  doi: 10.1016/0198-8859(84)90006-5
– volume: 25
  start-page: 585
  year: 1961
  ident: 13_CR11
  publication-title: Exp Cell Res
  doi: 10.1016/0014-4827(61)90192-6
– volume: 49
  start-page: B65
  year: 1994
  ident: 13_CR21
  publication-title: J Gerontol
  doi: 10.1093/geronj/49.2.B65
– volume: 22
  start-page: 361
  year: 2004
  ident: 13_CR25
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.22.012703.104644
– volume: 18
  start-page: 450
  year: 1997
  ident: 13_CR19
  publication-title: Immunology Today
  doi: 10.1016/S0167-5699(97)01079-7
– volume: 24
  start-page: 77
  year: 2003
  ident: 13_CR24
  publication-title: Neurobiol Aging
  doi: 10.1016/S0197-4580(02)00043-X
– volume: 39
  start-page: 875
  year: 2004
  ident: 13_CR2
  publication-title: Exp Gerontol
  doi: 10.1016/j.exger.2004.03.029
– volume: 38
  start-page: 1243
  year: 2003
  ident: 13_CR20
  publication-title: Exp Gerontol
  doi: 10.1016/j.exger.2003.09.004
– volume: 228
  start-page: 58
  year: 1996
  ident: 13_CR22
  publication-title: Exp Cell Res
  doi: 10.1006/excr.1996.0299
– volume: 37
  start-page: 614
  year: 1965
  ident: 13_CR10
  publication-title: Exp Cell Res
  doi: 10.1016/0014-4827(65)90211-9
– volume: 67
  start-page: 173
  year: 1993
  ident: 13_CR15
  publication-title: Mech Ageing Dev
  doi: 10.1016/0047-6374(93)90121-7
– volume: 7
  start-page: d1056
  year: 2002
  ident: 13_CR16
  publication-title: Front Biosci
  doi: 10.2741/A831
– volume: 39
  start-page: 879
  year: 2004
  ident: 13_CR4
  publication-title: Exp Gerontol
  doi: 10.1016/j.exger.2004.03.011
– volume: 193
  start-page: 1007
  year: 1976
  ident: 13_CR13
  publication-title: Science
  doi: 10.1126/science.181845
– volume: 39
  start-page: 879
  year: 2004
  ident: 13_CR3
  publication-title: Exp Gerontol
  doi: 10.1016/j.exger.2004.03.005
– volume: 268
  start-page: 154
  year: 1977
  ident: 13_CR12
  publication-title: Nature
  doi: 10.1038/268154a0
– volume-title: The Immunologic theory of aging
  year: 1969
  ident: 13_CR5
– volume: 307
  start-page: 208
  year: 2005
  ident: 13_CR23
  publication-title: Science
  doi: 10.1126/science.307.5707.208
– volume: 24
  start-page: 177
  year: 1989
  ident: 13_CR14
  publication-title: Exp Gerontol
  doi: 10.1016/0531-5565(89)90009-0
– volume-title: In isolation, characterization and utilization of T lymphocyte clones
  year: 1983
  ident: 13_CR18
– reference: 12103341 - Trends Immunol. 2002 Jul;23(7):330-2
– reference: 15032582 - Annu Rev Immunol. 2004;22:361-403
– reference: 7128889 - Dev Comp Immunol. 1982 Summer;6(3):391-3
– reference: 12817143 - Science. 2003 Jun 20;300(5627):1921
– reference: 15655081 - Science. 2005 Jan 14;307(5707):208-9; author reply 208-9
– reference: 14315085 - Exp Cell Res. 1965 Mar;37:614-36
– reference: 14698803 - Exp Gerontol. 2003 Nov-Dec;38(11-12):1243-9
– reference: 11991846 - Front Biosci. 2002 May 01;7:d1056-183
– reference: 13905658 - Exp Cell Res. 1961 Dec;25:585-621
– reference: 2786475 - Exp Gerontol. 1989;24(3):177-87
– reference: 8126348 - J Gerontol. 1994 Mar;49(2):B65-70
– reference: 145543 - Nature. 1977 Jul 14;268(5616):154-6
– reference: 9293162 - Immunol Today. 1997 Sep;18(9):450-4
– reference: 8892971 - Exp Cell Res. 1996 Oct 10;228(1):58-64
– reference: 6607244 - Hum Immunol. 1984 Jan;9(1):49-65
– reference: 12493553 - Neurobiol Aging. 2003 Jan-Feb;24(1):77-84
– reference: 15275638 - Trends Immunol. 2004 Aug;25(8):406-10
– reference: 8469029 - Mech Ageing Dev. 1993 Feb;67(1-2):173-85
– reference: 181845 - Science. 1976 Sep 10;193(4257):1007-8
SSID ssj0034964
Score 1.9140482
SecondaryResourceType review_article
Snippet Roy Walford died on April 27, 2004, at the age of 79. His contributions to gerontological research in such diverse areas as caloric restriction, genetics of...
Abstract Roy Walford died on April 27, 2004, at the age of 79. His contributions to gerontological research in such diverse areas as caloric restriction,...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 7
SubjectTerms Ageing
Immunity
Immunosenescence
Review
Walford
Title Roy Walford and the immunologic theory of aging
URI https://www.ncbi.nlm.nih.gov/pubmed/15850487
https://www.proquest.com/docview/1859467071
https://www.proquest.com/docview/20838781
https://pubmed.ncbi.nlm.nih.gov/PMC1131916
https://doaj.org/article/5e02f078af084405bc51410e188c7e70
Volume 2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1742-4933
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0034964
  issn: 1742-4933
  databaseCode: RBZ
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1742-4933
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0034964
  issn: 1742-4933
  databaseCode: DOA
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1742-4933
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0034964
  issn: 1742-4933
  databaseCode: M~E
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAVX
  databaseName: Springer Journals
  customDbUrl:
  eissn: 1742-4933
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0034964
  issn: 1742-4933
  databaseCode: RSV
  dateStart: 20041201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BBYgLguW1UIqRUE9EG2fjR46AWnGgFUJA92bZ3rFYsUrQ9iHtpb-dsZ0sXUTFhUsOziRyxhPPN_LMNwCva-ddLHksbFmFog6NLLTQruDoNIq5cDLxFnz7qI6P9WzWfLrS6ivmhGV64Ky4iUB6CfkxG0pdE7pwXsTURORae4UqReuEeoZgKu_BkQW9zqWQVVFTzD6wa2o52YwVBC23vFEi7f8b0vwzYfKKBzq8D_d66Mje5ik_gBvYjuB2bia5HsGdo_6YfAS7ueiWneAy2BWyfTYMdKsfD2HyuVuzE7uMee3MtnNGIJAtYqFI3glZqm5csy6w1MPoEXw9PPjy_kPRN04o_DSyqyrROGdt2ZSkoEp4qzzhADmtrEY5lR5LlKHijty1sFqWgdeuQWclejcXJPIYdtquxafA6FnXKB6ccKHWSACNACFHQlVKzxuFY3gzKND4nlU8NrdYmhRdaGmivk3Ut6mMGsP-RvxnptO4TvBdXI2NUGTBTgNkG6a3DfMv2xjDq2EtDf018SjEttidnxpCKQ25CMJXY3h5jQyZ1VQrTRJP8ur_njHFWLTz0STVll1szXb7Trv4nri7Oac9j8tn_-PznsPdRCRb1kUldmHnbHWOL-CWvzhbnK724Kaa6b30W9D16PLgF1DlDFo
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Roy+Walford+and+the+immunologic+theory+of+aging&rft.jtitle=Immunity+%26+ageing&rft.au=Effros%2C+Rita+B&rft.date=2005-04-25&rft.issn=1742-4933&rft.eissn=1742-4933&rft.volume=2&rft.issue=1&rft.spage=7&rft_id=info:doi/10.1186%2F1742-4933-2-7&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-4933&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-4933&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-4933&client=summon